BioHarvest Sciences Inc. announced on November 12, 2024, that its shares commenced trading on the Nasdaq Global Market under the new ticker symbol "BHST." The company's common shares will continue to trade on the Canadian Securities Exchange.
Ilan Sobel, Chief Executive Officer of BioHarvest Sciences, stated that the Nasdaq listing is a monumental milestone in the company's corporate history. This move is expected to elevate BioHarvest's public profile in the industry, improve liquidity, and significantly expand its potential shareholder base.
The uplisting is a strategic step to attract a broader base of U.S. investors and enhance shareholder value creation over the long term. This increased visibility on a senior U.S. exchange is crucial for the company's growth trajectory.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.